Intra-arterial and oral priscoline®

The action of intra-artenal priscoline ® supported by oral therapy has been studied intensively in seventeen cases of peripheral vascular disease. From the cases observed we may state that the drug is a valuable adjunct in two types of cases, namely, refractory leg ulcers prior to the onset of gangrene or established soft tissue necrosis and vasospasm whether due to trauma, the symptom complex of scleroderma or ulceration due to arteriosclerosis, diabetes or chronic thrombophlebitis.